SCHEMBL30830685

SCHEMBL30830685

CN1C[C@H](Nc2cnn(C)c(=O)c2Br)C[C@H](c2ccc(C(=O)N3CCN(C4CCC(N5CCC(=O)NC5=O)CC4)CC3)cc2)C1

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ KAT2B Q92831 14/20 0.55
▸ BRD9 Q9H8M2 3/20 0.55
▸ KAT2A Q92830 2/20 0.55
▸ BRD1 O95696 1/20 0.55
▸ ACHE P22303 1/20 0.55
▸ BRPF1 P55201 1/20 0.55
▸ BPTF Q12830 1/20 0.55
▸ BRD7 Q9NPI1 1/20 0.55
▸ BAZ2B Q9UIF8 1/20 0.55
▸ BRPF3 Q9ULD4 1/20 0.55
▸ L3MBTL3 Q96JM7 2/20 0.35
▸ L3MBTL1 Q9Y468 2/20 0.35
▸ TRPV6 Q9H1D0 1/20 0.35
▸ KDM4E B2RXH2 2/20 0.34
▸ RECQL P46063 1/20 0.34
▸ HRH3 Q9Y5N1 1/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ KMT2A Q03164 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30830500 0.89 KAT2B (0.54) KAT2BBRD9KAT2ABRD1ACHE
SCHEMBL30830518 0.89 KAT2B (0.54) KAT2BBRD9KAT2ABRD1ACHE
SCHEMBL30830917 0.88 KAT2B (0.56) KAT2BBRD9KAT2ABRD1ACHE
SCHEMBL30830684 0.85 KAT2B (0.56) KAT2BBRD9KAT2ABRD1ACHE
SCHEMBL30830723 0.84 KAT2B (0.53) KAT2BBRD9KAT2ABRD1ACHE
SCHEMBL30830768 0.83 KAT2B (0.58) KAT2BBRD9KAT2ABRD1ACHE
SCHEMBL30830541 0.83 KAT2B (0.52) KAT2BBRD9KAT2ABRD1ACHE
SCHEMBL30830571 0.82 KAT2B (0.55) KAT2BBRD9KAT2ABRD1ACHE
SCHEMBL30830850 0.82 KAT2B (0.53) KAT2BBRD9KAT2ABRD1ACHE
SCHEMBL30830603 0.82 KAT2B (0.51) KAT2BBRD9KAT2ABRD1ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4581025-A1 PYRIDAZINON DERIVATIVES AS KAT2 DEGRADERS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS Auron Therapeutics, Inc. (US) 2025-07-09 — — EP disclosed
WO-2024050078-A1 PYRIDAZINON DERIVATIVES AS KAT2 DEGRADERS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS AURON THERAPEUTICS, INC. (US) 2024-03-07 — — WO disclosed
Send feedback